A pivotal phase III trial of BL-8040

Trial Profile

A pivotal phase III trial of BL-8040

Planning
Phase of Trial: Phase III

Latest Information Update: 09 May 2017

At a glance

  • Drugs BL 8040 (Primary)
  • Indications Multiple myeloma
  • Focus Registrational; Therapeutic Use
  • Sponsors BioLineRx
  • Most Recent Events

    • 09 May 2017 New trial record
    • 03 May 2017 This trial is expected to begin in the second half of 2017, according to a BioLineRx media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top